[1. Jukic M, Husedžinovic I, Kvolik S, Majeric K.V, Peric M & Žunic J. (2013). Klinicka anesteziologija (2nd ed). Zagreb, Medicinska naklada.]Search in Google Scholar
[2. Rosenberg H, Pollock N, Schiemann A, Bulger T. & Stowell K. (2015). Malignant hyperthermia: a review. Orphanet J Rare Dis. 10:93. DOI: 10.1186/s13023-015-0310-1.10.1186/s13023-015-0310-1452436826238698]Search in Google Scholar
[3. Kollmann-Carnaiora A, Alsina E, Dominouez A, Del Blanco B, Yepes MJ, Guerrero JL. & Garcia A. (2017). Clinical protocol for the management hyperthermia. Rev Esp Anestesiol Reanim. 64(1):32-40. DOI: 10.1016/j.redar.2016.06.004.10.1016/j.redar.2016.06.00427633384]Open DOISearch in Google Scholar
[4. Metteriein T, Schuster F, Graf BM. & Anetseder M. (2014). Malignant hyperthermia. Anaesthesist. 63(12):908-18. DOI: 10.1007/s00101-014-2392-x.10.1007/s00101-014-2392-x25384957]Open DOISearch in Google Scholar
[5. Harison GG, Isaacs H. (1992). Malignant hyperthermia. An historical vignette. Anaesthesia. 47(1):54-6.]Search in Google Scholar
[6. Lalevic P, (1999). Anesteziologija. (1st ed). Beograd. Zavod za udžbenike i nastavna sredstva.]Search in Google Scholar
[7. Ording H. (1985). Incidence of malignant hyperthermia in Denmark. Anesth. Analg. 64(7):700-4.4014731]Search in Google Scholar
[8. Ibarra MC, Wu S, Murayama K, Minami N, Ichihara Y, Kikuchi H, et al. (2006). Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing. Anesthesiology. 104(6):1146-54.]Search in Google Scholar
[9. Butterworth FJ, Mackey CD. & Wasnick DJ. (2013). Morgan and Mikhails Clinical Anesthesiology. (5th ed). New York. Mc Graw Hill Education.]Search in Google Scholar
[10. Miller, Ronald D. (1994). Anesthesia. (4th ed). New York. Churchill Livingstone]Search in Google Scholar
[11. Osada H, Masuda K, Seki K, Sekiva S. (2004). Multiminicore disease with susceptibility to malignant hiperthermia in pregnanci. Ginecol Obstet Invest. 58(1):32-5.]Search in Google Scholar
[12. Lucy SJ. (1994). Anesthesia for caesarean delivery of a malignant hyperthermia susceptible parturient. Can J Anaesth. 41(12):1220-6.]Search in Google Scholar
[13. Bilmen JG, Gillies RI. (2014). Clarifying the role of activated charcoal filters in preparing an anaesthetic workstation for malignant hyperthermia-susceptible patients. Anaesth Intenzive Care. 42(1):51-8.]Search in Google Scholar
[14. Rosaeg OP, Morrison S, MacLeod JP. (1996). Anaesthetic management of labour and delivery in the parturient with mitochondrial myopathy. Can J Anaesth. 43(4):403-7.10.1007/BF030117228697558]Open DOISearch in Google Scholar
[15. Foster RN, Boothroyd KP. (2008). Caesarean section in a complicated case of central core disease. Anaesthesia, Journal of Association of Anasethetists of Great Britain and Ireland. 63: 544-7. DOI: 10.1111/j.1365-2044.2007.05411.x10.1111/j.1365-2044.2007.05411.x18412656]Open DOISearch in Google Scholar
[16. Goto S, Ogata K, Fujie T, Fujigaki T, Nakamura H, Yukinari T & Shibata O. (1993). Caesarean section in a patient with past history of fulminant malignant hyperthermia. Masui. 42(2):271-5.]Search in Google Scholar
[17. Malignant Hyperthermia Association of the USA-FAQS Molecular Genetics http://www.mhaus.org/faqs/molecular-genetics. Accessed 10 July 2015.]Search in Google Scholar
[18. European Malignant Hyperthermia Group http://www.emhg.org. Accessed 10 July 2015.]Search in Google Scholar